WA MTP Sector Spotlight featuring NovaCina

Our monthly event series is an opportunity for representatives from across the MTP sector to connect, collaborate and learn about upcoming opportunities, and hear the stories and successes of WA organisations developing health and medical innovations. Join us for networking and conversation over light refreshments afterwards.

At this Spotlight, you can find out more about NovaCina’s journey to becoming a CDMO in Perth, the strategic visions of the globally operating Bridgewest Group, and the future of pharmaceutical manufacturing in Western Australia.

+PLUS! Sign up for a tour of the NovaCina facilities before the Spotlight! Details below.

Details

Wednesday 19 June 2024, from 5:30pm-7:30pm AWST

Seminar Room, The Hub, 2 Brodie-Hall Drive, Bentley

About NovaCina

NovaCina is a Contract Development and Manufacturing Organisation (CDMO) based in Bentley offering premium sterile liquid pharmaceutical contract manufacturing services. The team has expertise spanning early-stage drug development, full-scale manufacturing, and advanced analytical studies.

NovaCina is owned by the Bridgewest Group, an investment company with a passion for innovation in technology and life sciences. For over 20 years, the Bridgewest Group has developed businesses with innovative solutions that improve the lives of patients and advance the field of medicine.

NovaCina’s facility has been in continuous operation for over thirty years, with NovaCina taking over the site from Pfizer in 2023.

About our speaker

Brett Alderson – President of NovaCina and COO of Bridgewest Perth Pharma

Brett Alderson is a seasoned veteran in the pharmaceutical industry predominantly working with the manufacturing of sterile injectables. Brett is a determined and thoughtful leader adept at driving business success and leading through change. He is a champion for customers, instilling a customer-centric culture with transparency and helpfulness. He enjoys mentoring and nurturing a diverse workforce with a clear imperative of open and honest communication. Brett has a reputation as an energetic problem solver, acting with integrity and care, and always encourages solutions for a brighter tomorrow by empowering people.

Brett’s career includes more than 25 years at Pfizer (Perth) Pty Ltd., including 5 years as Site Lead. Where he oversaw a 400-member team and the production of sterile injectable medicines for local and global markets.

Brett has a bachelor’s degree in applied science in Chemistry from Curtin University.